Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amarin Corporation plc
Neuroscience company raises $12.75M in private placement
November 6th, 2004
Amarin Corporation plc (AMRN) announced that it has completed a private placement of 13,448,546 ordinary shares to a group of new and existing accredited investors and management, raising gross proceeds to the company of $12.75 million, which will fund development of Miraxion. The purchase price of $0.947 per share was based on the average closing price of Amarin's American Depositary Shares on Nasdaq for the 10 trading days ended October 6, 2004. Amarin intends to file a registration statement with the U.S. Securities and Exchange Commission within 60 days covering the ordinary shares sold to investors. As previously announced, following Thomas...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
